查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1420930

免疫分析市场 - 2023-2031 年全球产业分析、规模、份额、成长、趋势与预测

Immunoassay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 336 Pages | 商品交期: 2-10个工作天内

价格

免疫分析市场 - 报告范围

TMR 关于全球免疫分析市场的报告研究了过去以及当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了该期间全球免疫分析市场的收入2017-2031年，以2023年为基准年，2031年为预测年。报告中也提供了2023年至2031年全球免疫分析市场的年复合成长率（CAGR %）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解免疫分析市场。

市场概况
2023年市场价值 315 亿美元
2031 年市场价值 487 亿美元
CAGR 5%

该报告深入探讨了全球免疫分析市场的竞争格局。全球免疫分析市场的主要参与者已被确定，并且每一位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球免疫分析市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2017-2031年全球市场分析与预测

第 5 章：关键见解

  • 管道分析
  • 主要产品/品牌分析
  • 主要併购
  • COVID-19 大流行对该行业的影响

第 6 章：全球市场分析与预测：依产品分类

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按产品，2017-2031
    • 分析仪
    • 耗材
  • 市场吸引力：依产品分类

第 7 章：全球市场分析与预测：依技术分类

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依技术分类，2017-2031
    • 化学发光（CLIA）
    • 酶联 (ELISA)
    • 酵素连结免疫萤光分析 (ELFA)
    • 广播电台（RIA）
    • 其他的
    • 7.4 市场吸引力：依技术分类

第 8 章：全球市场分析与预测：按应用分类

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依应用分类，2017-2031
    • 传染病
    • 内分泌科
    • 肿瘤学
    • 心臟病学
    • 骨科
    • 其他的
  • 市场吸引力：按应用分类

第 9 章：全球市场分析与预测：按最终用户

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2017-2031
    • 医院和诊断实验室
    • 血库
    • 其他的
  • 市场吸引力：按最终用户划分

第 10 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2017-2031
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力：按地区

第 11 章：北美市场分析与预测

第 12 章：欧洲市场分析与预测

第 13 章：亚太市场分析与预测

第 14 章：拉丁美洲市场分析与预测

第 15 章：中东和非洲市场分析与预测

第16章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司划分（2022 年）
  • 公司简介
    • F. Hoffmann-La Roche Ltd.
    • Danaher Corporation
    • Abbott Laboratories
    • Siemens Healthineers (Siemens AG)
    • DiaSorin SpA
    • Sysmex Corporation
    • bioMerieux SA
    • Ortho Clinical Diagnostics
    • Thermo Fisher Scientific, Inc.
    • Becton, Dickinson and Company
    • Merck kGaA
Product Code: TMRGL19703

Immunoassay Market - Scope of Report

TMR's report on the global immunoassay market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global immunoassay market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global immunoassay market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the immunoassay market.

Market Snapshot
Market Value in 2023US$ 31.5 Bn
Market Value in 2031US$ 48.7 Bn
CAGR5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global immunoassay market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global immunoassay market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global immunoassay market.

The report delves into the competitive landscape of the global immunoassay market. Key players operating in the global immunoassay market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global immunoassay market profiled in this report.

Key Questions Answered in Global immunoassay Market Report:

  • What is the sales/revenue generated by immunoassay across all regions during the forecast period?
  • What are the opportunities in the global immunoassay market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Immunoassay Market - Research Objectives and Research Approach

The comprehensive report on the global immunoassay market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global immunoassay market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global immunoassay market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Immunoassay Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Immunoassay Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Immunoassay Market Analysis and Forecast, by Product

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Analyzers
    • 6.3.2. Consumables
  • 6.4. Market Attractiveness, by Product

7. Global Immunoassay Market Analysis and Forecast, by Technology

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Technology, 2017-2031
    • 7.3.1. Chemiluminescence Immunoassay (CLIA)
    • 7.3.2. Enzyme-linked Immunoassay (ELISA)
    • 7.3.3. Enzyme-linked Immunofluorescent Assay (ELFA)
    • 7.3.4. Radioimmunoassay (RIA)
    • 7.3.5. Others
    • 7.3.6. 7.4 Market Attractiveness, by Technology

8. Global Immunoassay Market Analysis and Forecast, by Application

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Application, 2017-2031
    • 8.3.1. Infectious Disease
    • 8.3.2. Endocrinology
    • 8.3.3. Oncology
    • 8.3.4. Cardiology
    • 8.3.5. Orthopedics
    • 8.3.6. Others
  • 8.4. Market Attractiveness, by Application

9. Global Immunoassay Market Analysis and Forecast, by End-user

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Hospitals & Diagnostic Laboratories
    • 9.3.2. Blood Banks
    • 9.3.3. Others
  • 9.4. Market Attractiveness, by End-user

10. Global Immunoassay Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2017-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness, by Region

11. North America Immunoassay Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2017-2031
    • 11.2.1. Analyzers
    • 11.2.2. Consumables
  • 11.3. Market Attractiveness, by Product
  • 11.4. Market Value Forecast, by Technology, 2017-2031
    • 11.4.1. Chemiluminescence Immunoassay (CLIA)
    • 11.4.2. Enzyme-linked Immunoassay (ELISA)
    • 11.4.3. Enzyme-linked Immunofluorescent Assay (ELFA)
    • 11.4.4. Radioimmunoassay (RIA)
    • 11.4.5. Others
  • 11.5. Market Attractiveness, by Technology
  • 11.6. Market Value Forecast, by Application, 2017-2031
    • 11.6.1. Infectious Disease
    • 11.6.2. Endocrinology
    • 11.6.3. Oncology
    • 11.6.4. Cardiology
    • 11.6.5. Orthopedics
    • 11.6.6. Others
  • 11.7. Market Attractiveness, by Application
  • 11.8. Market Value Forecast, by End-user, 2017-2031
    • 11.8.1. Hospitals & Diagnostic Laboratories
    • 11.8.2. Blood Banks
    • 11.8.3. Others
  • 11.9. Market Attractiveness, by End-user
  • 11.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.10.1. U.S.
    • 11.10.2. Canada
  • 11.11. Market Attractiveness Analysis
    • 11.11.1. By Product
    • 11.11.2. By Technology
    • 11.11.3. By Application
    • 11.11.4. By End-user
    • 11.11.5. By Country

12. Europe Immunoassay Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2017-2031
    • 12.2.1. Analyzers
    • 12.2.2. Consumables
  • 12.3. Market Attractiveness, by Product
  • 12.4. Market Value Forecast, by Technology, 2017-2031
    • 12.4.1. Chemiluminescence Immunoassay (CLIA)
    • 12.4.2. Enzyme-linked Immunoassay (ELISA)
    • 12.4.3. Enzyme-linked Immunofluorescent Assay (ELFA)
    • 12.4.4. Radioimmunoassay (RIA)
    • 12.4.5. Others
  • 12.5. Market Attractiveness, by Technology
  • 12.6. Market Value Forecast, by Application, 2017-2031
    • 12.6.1. Infectious Disease
    • 12.6.2. Endocrinology
    • 12.6.3. Oncology
    • 12.6.4. Cardiology
    • 12.6.5. Orthopedics
    • 12.6.6. Others
  • 12.7. Market Attractiveness, by Application
  • 12.8. Market Value Forecast, by End-user, 2017-2031
    • 12.8.1. Hospitals & Diagnostic Laboratories
    • 12.8.2. Blood Banks
    • 12.8.3. Others
  • 12.9. Market Attractiveness, by End-user
  • 12.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.10.1. Germany
    • 12.10.2. U.K.
    • 12.10.3. France
    • 12.10.4. Italy
    • 12.10.5. Spain
    • 12.10.6. Rest of Europe
  • 12.11. Market Attractiveness Analysis
    • 12.11.1. By Product
    • 12.11.2. By Technology
    • 12.11.3. By Application
    • 12.11.4. By End-user
    • 12.11.5. By Country/Sub-region

13. Asia Pacific Immunoassay Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2017-2031
    • 13.2.1. Analyzers
    • 13.2.2. Consumables
  • 13.3. Market Attractiveness, by Product
  • 13.4. Market Value Forecast, by Technology, 2017-2031
    • 13.4.1. Chemiluminescence Immunoassay (CLIA)
    • 13.4.2. Enzyme-linked Immunoassay (ELISA)
    • 13.4.3. Enzyme-linked Immunofluorescent Assay (ELFA)
    • 13.4.4. Radioimmunoassay (RIA)
    • 13.4.5. Others
  • 13.5. Market Attractiveness, by Technology
  • 13.6. Market Value Forecast, by Application, 2017-2031
    • 13.6.1. Infectious Disease
    • 13.6.2. Endocrinology
    • 13.6.3. Oncology
    • 13.6.4. Cardiology
    • 13.6.5. Orthopedics
    • 13.6.6. Others
  • 13.7. Market Attractiveness, by Application
  • 13.8. Market Value Forecast, by End-user, 2017-2031
    • 13.8.1. Hospitals & Diagnostic Laboratories
    • 13.8.2. Blood Banks
    • 13.8.3. Others
  • 13.9. Market Attractiveness, by End-user
  • 13.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.10.1. China
    • 13.10.2. Japan
    • 13.10.3. India
    • 13.10.4. Australia & New Zealand
    • 13.10.5. Rest of Asia Pacific
  • 13.11. Market Attractiveness Analysis
    • 13.11.1. By Product
    • 13.11.2. By Technology
    • 13.11.3. By Application
    • 13.11.4. By End-user
    • 13.11.5. By Country/Sub-region

14. Latin America Immunoassay Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2017-2031
    • 14.2.1. Analyzers
    • 14.2.2. Consumables
  • 14.3. Market Attractiveness, by Product
  • 14.4. Market Value Forecast, by Technology, 2017-2031
    • 14.4.1. Chemiluminescence Immunoassay (CLIA)
    • 14.4.2. Enzyme-linked Immunoassay (ELISA)
    • 14.4.3. Enzyme-linked Immunofluorescent Assay (ELFA)
    • 14.4.4. Radioimmunoassay (RIA)
    • 14.4.5. Others
  • 14.5. Market Attractiveness, by Technology
  • 14.6. Market Value Forecast, by Application, 2017-2031
    • 14.6.1. Infectious Disease
    • 14.6.2. Endocrinology
    • 14.6.3. Oncology
    • 14.6.4. Cardiology
    • 14.6.5. Orthopedics
    • 14.6.6. Others
  • 14.7. Market Attractiveness, by Application
  • 14.8. Market Value Forecast, by End-user, 2017-2031
    • 14.8.1. Hospitals & Diagnostic Laboratories
    • 14.8.2. Blood Banks
    • 14.8.3. Others
  • 14.9. Market Attractiveness, by End-user
  • 14.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.10.1. Brazil
    • 14.10.2. Mexico
    • 14.10.3. Rest of Latin America
  • 14.11. Market Attractiveness Analysis
    • 14.11.1. By Product
    • 14.11.2. By Technology
    • 14.11.3. By Application
    • 14.11.4. By End-user
    • 14.11.5. By Country/Sub-region

15. Middle East & Africa Immunoassay Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product, 2017-2031
    • 15.2.1. Analyzers
    • 15.2.2. Consumables
  • 15.3. Market Attractiveness, by Product
  • 15.4. Market Value Forecast, by Technology, 2017-2031
    • 15.4.1. Chemiluminescence Immunoassay (CLIA)
    • 15.4.2. Enzyme-linked Immunoassay (ELISA)
    • 15.4.3. Enzyme-linked Immunofluorescent Assay (ELFA)
    • 15.4.4. Radioimmunoassay (RIA)
    • 15.4.5. Others
  • 15.5. Market Attractiveness, by Technology
  • 15.6. Market Value Forecast, by Application, 2017-2031
    • 15.6.1. Infectious Disease
    • 15.6.2. Endocrinology
    • 15.6.3. Oncology
    • 15.6.4. Cardiology
    • 15.6.5. Orthopedics
    • 15.6.6. Others
  • 15.7. Market Attractiveness, by Application
  • 15.8. Market Value Forecast, by End-user, 2017-2031
    • 15.8.1. Hospitals & Diagnostic Laboratories
    • 15.8.2. Blood Banks
    • 15.8.3. Others
  • 15.9. Market Attractiveness, by End-user
  • 15.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.10.1. GCC Countries
    • 15.10.2. South Africa
    • 15.10.3. Rest of Middle East & Africa
  • 15.11. Market Attractiveness Analysis
    • 15.11.1. By Product
    • 15.11.2. By Technology
    • 15.11.3. By Application
    • 15.11.4. By End-user
    • 15.11.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. F. Hoffmann-La Roche Ltd.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Danaher Corporation
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Abbott Laboratories
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Siemens Healthineers (Siemens AG)
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. DiaSorin S.p.A.
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Sysmex Corporation
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. bioMerieux SA
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Ortho Clinical Diagnostics
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Thermo Fisher Scientific, Inc.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Becton, Dickinson and Company
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. Merck kGaA
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Product Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview

List of Tables

  • Table 01: Global Immunoassay Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 02: Global Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 03: Global Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Immunoassay Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 05: Global Immunoassay Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Immunoassay Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America Immunoassay Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 08: North America Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 09: North America Immunoassay Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 10: North America Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 11: Europe Immunoassay Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe Immunoassay Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 13: Europe Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 14: Europe Immunoassay Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 15: Europe Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 18: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 19: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 20: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Latin America Immunoassay Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America Immunoassay Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 23: Latin America Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 24: Latin America Immunoassay Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 25: Latin America Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 26: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 28: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 29: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 30: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Immunoassay Market Size (US$ Mn), by Region, 2022 and 2031
  • Figure 02: Global Immunoassay Market Revenue (US$ Mn), by Product, 2022
  • Figure 03: Global Immunoassay Market Value Share, by Product, 2022
  • Figure 04: Global Immunoassay Market Revenue (US$ Mn), by Technology, 2022
  • Figure 05: Global Immunoassay Market Value Share, by Technology, 2022
  • Figure 06: Global Immunoassay Market Revenue (US$ Mn), by Application, 2022
  • Figure 07: Global Immunoassay Market Value Share, by Application, 2022
  • Figure 08: Global Immunoassay Market Revenue (US$ Mn), by End-user, 2022
  • Figure 09: Global Immunoassay Market Value Share, by End-user, 2022
  • Figure 10: Global Immunoassay Market Value Share, by Region, 2022
  • Figure 11: Global Immunoassay Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 12: Global Immunoassay Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 13: Global Immunoassay Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 14: Global Immunoassay Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 15: Global Immunoassay Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 16: Global Immunoassay Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 17: Global Immunoassay Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 18: Global Immunoassay Market Revenue (US$ Mn), by End-user, 2022
  • Figure 19: Global Immunoassay Market Value Share, by End-user, 2022
  • Figure 20: Global Immunoassay Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 21: Global Immunoassay Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 22: North America Immunoassay Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 23: North America Immunoassay Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 24: North America Immunoassay Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 25: North America Immunoassay Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 26: North America Immunoassay Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 27: North America Immunoassay Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 28: North America Immunoassay Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 29: North America Immunoassay Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 30: North America Immunoassay Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 31: North America Immunoassay Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 32: North America Immunoassay Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 33: Europe Immunoassay Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 34: Europe Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 35: Europe Immunoassay Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 36: Europe Immunoassay Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 37: Europe Immunoassay Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 38: Europe Immunoassay Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 39: Europe Immunoassay Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 40: Europe Immunoassay Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 41: Europe Immunoassay Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 42: Europe Immunoassay Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 43: Europe Immunoassay Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 44: Asia Pacific Immunoassay Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 45: Asia Pacific Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 46: Asia Pacific Immunoassay Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 47: Asia Pacific Immunoassay Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 48: Asia Pacific Immunoassay Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 49: Asia Pacific Immunoassay Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 50: Asia Pacific Immunoassay Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 51: Asia Pacific Immunoassay Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 52: Asia Pacific Immunoassay Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 53: Asia Pacific Immunoassay Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 54: Asia Pacific Immunoassay Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 55: Latin America Immunoassay Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 56: Latin America Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 57: Latin America Immunoassay Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 58: Latin America Immunoassay Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 59: Latin America Immunoassay Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 60: Latin America Immunoassay Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 61: Latin America Immunoassay Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 62: Latin America Immunoassay Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 63: Latin America Immunoassay Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 64: Latin America Immunoassay Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 65: Latin America Immunoassay Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 66: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 67: Middle East & Africa Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 68: Middle East & Africa Immunoassay Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 69: Middle East & Africa Immunoassay Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 70: Middle East & Africa Immunoassay Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 71: Middle East & Africa Immunoassay Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 72: Middle East & Africa Immunoassay Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 73: Middle East & Africa Immunoassay Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 74: Middle East & Africa Immunoassay Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 75: Middle East & Africa Immunoassay Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 76: Middle East & Africa Immunoassay Market Attractiveness Analysis, by End-user, 2023-2031